JP2025501414A5 - - Google Patents

Info

Publication number
JP2025501414A5
JP2025501414A5 JP2024561738A JP2024561738A JP2025501414A5 JP 2025501414 A5 JP2025501414 A5 JP 2025501414A5 JP 2024561738 A JP2024561738 A JP 2024561738A JP 2024561738 A JP2024561738 A JP 2024561738A JP 2025501414 A5 JP2025501414 A5 JP 2025501414A5
Authority
JP
Japan
Prior art keywords
patient
nitric oxide
ino
dose
ibw
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024561738A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025501414A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/060080 external-priority patent/WO2023133399A1/en
Publication of JP2025501414A publication Critical patent/JP2025501414A/ja
Publication of JP2025501414A5 publication Critical patent/JP2025501414A5/ja
Pending legal-status Critical Current

Links

JP2024561738A 2022-01-04 2023-01-04 サルコイドーシスに関連する肺高血圧症(PH-SARC)を有する患者を治療するための一酸化窒素吸入療法(iNO)の使用 Pending JP2025501414A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US202263296359P 2022-01-04 2022-01-04
US63/296,359 2022-01-04
US202263341986P 2022-05-13 2022-05-13
US63/341,986 2022-05-13
US202263342535P 2022-05-16 2022-05-16
US63/342,535 2022-05-16
PCT/US2023/060080 WO2023133399A1 (en) 2022-01-04 2023-01-04 Use of inhaled nitric oxide (ino) for treating patients with pulmonary hypertension associated with sarcoidosis (ph-sarc)

Publications (2)

Publication Number Publication Date
JP2025501414A JP2025501414A (ja) 2025-01-17
JP2025501414A5 true JP2025501414A5 (cg-RX-API-DMAC7.html) 2026-01-08

Family

ID=87074247

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024561738A Pending JP2025501414A (ja) 2022-01-04 2023-01-04 サルコイドーシスに関連する肺高血圧症(PH-SARC)を有する患者を治療するための一酸化窒素吸入療法(iNO)の使用

Country Status (10)

Country Link
US (1) US20250302869A1 (cg-RX-API-DMAC7.html)
EP (1) EP4460369A4 (cg-RX-API-DMAC7.html)
JP (1) JP2025501414A (cg-RX-API-DMAC7.html)
KR (1) KR20240145466A (cg-RX-API-DMAC7.html)
CN (1) CN119095604A (cg-RX-API-DMAC7.html)
AU (1) AU2023205912A1 (cg-RX-API-DMAC7.html)
CA (1) CA3242496A1 (cg-RX-API-DMAC7.html)
MX (1) MX2024008126A (cg-RX-API-DMAC7.html)
TW (1) TW202345876A (cg-RX-API-DMAC7.html)
WO (1) WO2023133399A1 (cg-RX-API-DMAC7.html)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013132497A1 (en) * 2012-03-07 2013-09-12 Advanced Inhilation Therapies (Ait) Ltd. Inhalation of nitric oxide for treating respiratory diseases
CA2892398C (en) * 2012-12-04 2023-02-14 Ino Therapeutics Llc Cannula for minimizing dilution of dosing during nitric oxide delivery
KR20200127158A (ko) * 2017-12-28 2020-11-10 벨레로폰 펄스 테크놀로지스 엘엘씨 폐고혈압의 치료를 위한 흡입 산화질소의 펄스식 투여
CN112584761B (zh) * 2018-05-17 2025-08-29 万灵科制药爱尔兰有限公司 脉动式输送一氧化氮的方法和装置
WO2020142658A1 (en) * 2019-01-04 2020-07-09 Bellerophon Therapeutics Use of inhaled nitric oxide (ino) for improving activity levels in patients with lung-related conditions

Similar Documents

Publication Publication Date Title
AU2018394928B2 (en) Use of inhaled nitric oxide and oxygen for the treatment of pulmonary hypertension
Mutoh et al. Cardiopulmonary effects of sevoflurane, compared with halothane, enflurane, and isoflurane, in dogs
JP3834337B2 (ja) 麻酔時の呼吸維持装置
JP7813138B2 (ja) 肺に関連する状態を有する患者における活動レベルを改善するための一酸化窒素吸入療法(iNO)の使用
Stock et al. The PaCO2 rate of rise in anesthetized patients with airway obstruction
KR20010005502A (ko) 수술 후에 환자로부터 증기 마취제를 제거하는 방법
Glenn et al. Diaphragm pacing: application to a patient with chronic obstructive pulmonary disease
US20130302445A1 (en) Apparatus and method for treating cerebral ischemia using non-inhaled carbon dioxide
Walpole et al. Effect of sevoflurane concentration on inhalation induction of anaesthesia in the elderly
Joad et al. Nitric oxide contributes to substance P-induced increases in lung rapidly adapting receptor activity in guinea-pigs
Mutoh et al. Effects of medetomidine-midazolam, midazolambutorphanol, or acepromazine-butorphanol as premedicants for mask induction of anesthesia with sevoflurane in dogs
Mutoh et al. Effects of nitrous oxide on mask induction of anesthesia with sevoflurane or isoflurane in dogs
Brundin et al. Effect of intermittent positive pressure ventilation on cardiac systolic time intervals
RU2839350C1 (ru) Способ коррекции кислородной зависимости при сохраненном спонтанном дыхании
Sullivan et al. Ventilatory response during CO2 inhalation after airway anesthesia with lidocaine
SU1124970A1 (ru) Способ лечени гипотонической болезни
HK40127956A (en) Use of inhaled nitric oxide and oxygen for the treatment of pulmonary hypertension
Tammesto et al. The role of thiopental and fentanyl in the production of balanced anaesthesia
RU2203691C2 (ru) Способ профилактики и лечения заболеваний, в том числе вызванных изменениями климатических условий, неблагоприятными факторами среды обитания, особенно повышенным содержанием углекислого газа, с использованием эндогенного дыхания
Hubbell et al. Management of intravenous anesthesia to control recovery time
JP2025501414A (ja) サルコイドーシスに関連する肺高血圧症(PH-SARC)を有する患者を治療するための一酸化窒素吸入療法(iNO)の使用
Gasthuys et al. Time‐related responses to a constant‐dose halothane anaesthesia in dorsally recumbent ventilated ponies
Lal et al. Oxygen administration after myocardial infarction
RU2665183C1 (ru) Способ профилактики брадикардии при ингаляционной индукции в анестезию севофлюраном у детей
Ratnam et al. Treatment of disease without the use of drugs. IV. Self-treatment of asthma by thought control and breathing exercises